Walk Your Portfolio to the Vet
In a recent story, I discussed the preformance of nutritional-supplement makers, which I was motivated to scan when I saw Thursday's news about Blyth's (BTH) planned spinoff of supplement maker ViSalus.
Another initial public offering in the works is Pfizer's (PFE) spinoff of its animal healthcare unit. The company, named Zoetis, filed for an IPO earlier this week. This will likely be a large offering, as Zoetis is already bringing in $4.2 billion a year in revenue. The company has 9,000 employees -- not exactly a scrappy garage startup. ...470 more words left in this article. To read them, just click below and try Real Money FREE for 14 days.
There’s no substitute for a trading floor to get great ideas, so Jim Cramer created a better one at Real Money and blogs there exclusively. We then added legendary hedge fund manager, Doug Kass, with his exclusive Daily Diary and best investing ideas. Staffed with more than 4 dozen investing pros, money managers, journalists and analysts, Real Money Pro gives you a flood of opinions, analysis and actionable trading advice found nowhere else, and allows you to interact directly with each expert.
Already a Subscriber? Please login.